Olympus Corp (7733) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Olympus Corp (Olympus) is a medical technology company. It develops, manufactures, and commercializes equipment and devices for medical, healthcare, imaging, information, and other industrial markets. Olympus' major products include endoscopes, laparoscopes, surgical energy devices, and instruments for disease prevention, detection, and treatment. The company’s products find application across various medical fields including endotherapy, respiratory, urology, gynecology, ear, nose, and throat, and surgical devices. It also offers biomedical materials and system development services. The company has an operational presence in the Americas, Europe and Asia-Pacific. Olympus Corp is headquartered in Hachioji-shi, Tokyo, Japan.
Olympus Corp Key Recent Developments
Jul 22, 2026: AcuityMD Now Trusted by More Than 500 Medical Device Companies, Including 16 of Top 20
Jun 24, 2026: Olympus Announces Reseller Agreement With First Nation Group for Federal Healthcare Distribution
Jun 24, 2026: Olympus Launches 4K LCD Monitors to Enhance Clarity in Endoscopic Diagnosis and Therapy
May 05, 2026: Olympus to distribute EndoRobotics' technologies worldwide
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
JGC Holdings Corp - Key Facts
JGC Holdings Corp - Key Employees
JGC Holdings Corp - Key Employee Biographies
JGC Holdings Corp - Major Products and Services
JGC Holdings Corp - History
JGC Holdings Corp - Company Statement
JGC Holdings Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 - Company Analysis
Company Overview
JGC Holdings Corp - Business Description
Business Segment: Functional Materials Manufacturing
Overview
Performance
Key Stats
Business Segment: Other
Overview
Performance
Key Stats
Business Segment: Total Engineering
Overview
Performance
Key Stats
Geographical Segment: Africa
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Middle East
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other
Performance
Geographical Segment: Southeast Asia
Performance
R&D Overview
JGC Holdings Corp - Corporate Strategy
JGC Holdings Corp - SWOT Analysis
SWOT Analysis - Overview
JGC Holdings Corp - Strengths
JGC Holdings Corp - Weaknesses
JGC Holdings Corp - Opportunities
JGC Holdings Corp - Threats
JGC Holdings Corp - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
JGC Holdings Corp, Recent Deals Summary
Section 4 - Company’s Recent Developments
Jun 08, 2026: JGC Joint Venture Awarded EPCIC Contract for Coral North Project in Mozambique
Jun 08, 2026: Technip Energies Secures Major Contract for Coral Norte Floating LNG Project in Mozambique
Jun 02, 2026: Fluor JV receives LNTP for LNG Canada phase two expansion
May 26, 2026: JGC Begins Work on Standardized FLNG Plant Design Package
Mar 31, 2026: JGC-Hyundai Joint Venture Secures EPC Contract for Major Low-Carbon LNG Plant Project in Papua New Guinea
Mar 25, 2026: JGC Holdings Signs Partnership Agreement With Nerima Ward to Promote Resource Recovery of Used Cooking Oil
Feb 24, 2026: Technip and partners win contract for Coral Norte FLNG project
Feb 19, 2026: Akashi City, JGC Holdings Corporation, Revo International Co., Ltd. and LLC SAFFAIRE SKY ENERGY Collaborate to Promote Resource Recovery of Used Cooking Oil
Feb 17, 2026: JGC Holdings, Revo International and SAFFAIRE SKY ENERGY Promote Resource Recovery of Used Cooking Oil for SAF
Jan 28, 2026: Green Ammonia Demonstration Plant of JGC Begins Producing Ammonia Using Hydrogen from Asahi Kasei
Section 5 - Appendix
Methodology
Ratio Definitions
About the Analyst
Contact the Publisher
Disclaimer
List of Tables
JGC Holdings Corp, Key Facts
JGC Holdings Corp, Key Employees
JGC Holdings Corp, Key Employee Biographies
JGC Holdings Corp, Major Products and Services
JGC Holdings Corp, History
JGC Holdings Corp, Other Locations
JGC Holdings Corp, Subsidiaries
JGC Holdings Corp, Joint Venture
JGC Holdings Corp, Key Competitors
JGC Holdings Corp, Ratios based on current share price
This product is a company SWOT Analysis. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a company SWOT Analysis. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a company SWOT Analysis. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net